This company has been acquired
Forma Therapeutics Holdings Dirección
Dirección controles de criterios 1/4
Información clave
Frank Lee
Chief Executive Officer (CEO)
US$9.3m
Compensación total
| Porcentaje del salario del CEO | 6.7% |
| Permanencia del CEO | 3.6yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 1.5yrs |
| Promedio de permanencia en la Junta Directiva | 3.3yrs |
Actualizaciones recientes de la dirección
Recent updates
We're Keeping An Eye On Forma Therapeutics Holdings' (NASDAQ:FMTX) Cash Burn Rate
Aug 30
Forma Therapeutics GAAP EPS of -$1.10 misses by $0.11
Aug 05We're Hopeful That Forma Therapeutics Holdings (NASDAQ:FMTX) Will Use Its Cash Wisely
Mar 04We're Hopeful That Forma Therapeutics Holdings (NASDAQ:FMTX) Will Use Its Cash Wisely
Nov 20Here's Why We're Not Too Worried About Forma Therapeutics Holdings' (NASDAQ:FMTX) Cash Burn Situation
Aug 13We Think Forma Therapeutics Holdings (NASDAQ:FMTX) Needs To Drive Business Growth Carefully
Apr 18What Type Of Shareholders Own The Most Number of Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) Shares?
Jan 03Forma Therapeutics closes public offering priced at $45.25
Dec 16Forma Therapeutics prices equity offering at $45.25
Dec 11Forma Therapeutics' sickle cell treatment shows promising action at ASH presentation
Dec 08Forma Therapeutics EPS beats by $0.01
Nov 12Forma Therapeutics' sickle cell candidate an orphan drug in Europe
Nov 10Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$190m |
| Mar 31 2022 | n/a | n/a | -US$181m |
| Dec 31 2021 | US$9m | US$620k | -US$173m |
| Sep 30 2021 | n/a | n/a | -US$151m |
| Jun 30 2021 | n/a | n/a | -US$136m |
| Mar 31 2021 | n/a | n/a | -US$119m |
| Dec 31 2020 | US$6m | US$575k | -US$74m |
| Sep 30 2020 | n/a | n/a | -US$74m |
| Jun 30 2020 | n/a | n/a | -US$78m |
| Mar 31 2020 | n/a | n/a | -US$61m |
| Dec 31 2019 | US$4m | US$442k | -US$53m |
Compensación vs. Mercado: Frank's total compensation ($USD9.31M) is above average for companies of similar size in the US market ($USD4.11M).
Compensación vs. Ingresos: Frank's compensation has increased whilst the company is unprofitable.
CEO
Frank Lee (54 yo)
3.6yrs
Permanencia
US$9,307,807
Compensación
Mr. Frank D. Lee is Chair of the Board of Catamaran Bio, Inc. from April 2022. He serves as an Independent Director at Bolt Biotherapeutics, Inc. since November 2021. Mr. Lee is Chief Executive Officer of...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 3.6yrs | US$9.31m | sin datos | |
| Senior VP & CFO | 3.1yrs | US$3.03m | 0% $ 0 | |
| Senior VP & Chief Technology Officer | 1.3yrs | sin datos | 0% $ 0 | |
| Senior VP & Chief Scientific Officer | 2.5yrs | sin datos | 0.087% $ 829.8k | |
| Head of Investor Relations | no data | sin datos | sin datos | |
| Senior VP | 3.1yrs | sin datos | 0% $ 0 | |
| Vice President of Commercial Strategy & Marketing | less than a year | sin datos | sin datos | |
| Senior Vice President & Chief Human Resources Officer | less than a year | sin datos | sin datos | |
| Senior Vice President of Commercial | 1.8yrs | sin datos | 0% $ 0 | |
| Senior VP & Chief Patient Officer | less than a year | sin datos | sin datos | |
| Executive Vice President | less than a year | sin datos | sin datos | |
| Treasurer | no data | sin datos | sin datos |
1.5yrs
Permanencia media
57yo
Promedio de edad
Equipo directivo experimentado: FMTX's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 3.8yrs | US$9.31m | sin datos | |
| Independent Non-Executive Director | 2.1yrs | US$253.39k | 0% $ 0 | |
| Independent Non-Executive Chairman | 9.9yrs | US$294.14k | 0% $ 0 | |
| Independent Non-Executive Director | 8yrs | US$265.14k | 0% $ 0 | |
| Independent Non-Executive Director | 4.6yrs | US$253.64k | 0% $ 0 | |
| Independent Non-Executive Director | 2.8yrs | US$253.39k | 0% $ 0 | |
| Independent Director | less than a year | sin datos | sin datos | |
| Independent Non-Executive Director | 2.3yrs | US$255.02k | 0% $ 0 |
3.3yrs
Permanencia media
60yo
Promedio de edad
Junta con experiencia: FMTX's board of directors are considered experienced (3.3 years average tenure).